VVOSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Vivos Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.13+0.00 (+2.90%)
Close on Oct 19, 2026
- Market cap
- $2.39M
- P/E (TTM)
- –
- Dividend yield
- –
Vivos Therapeutics, Inc. revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Service [Member] | $3.80M | $3.70M | $3.23M | $4.59M | $1.94M | $1.20M | $1.43M | $1.90M | $2.08M | $1.75M | $1.76M | $1.84M | 73.7% | +96.3% |
| Sleep Testing Services [Member] | $2.39M | $2.30M | $2.31M | $2.56M | $844.00K | $323.00K | $328.00K | $329.00K | $318.00K | $307.00K | $303.00K | $308.00K | 46.4% | +183.4% |
| Product [Member] | $1.36M | $1.44M | $594.00K | $2.20M | $1.89M | $1.81M | $2.27M | $1.96M | $1.98M | $1.67M | $1.49M | $1.47M | 26.3% | -28.1% |
| Treatment Centers [Member] | $767.00K | $892.00K | $616.00K | $1.32M | – | – | – | – | – | – | – | – | 14.9% | – |
| Tooth Positioners [Member] | $715.00K | $1.02M | – | – | $857.00K | $540.00K | – | – | – | – | – | – | 13.9% | -16.6% |
| Appliances [Member] | $640.00K | $422.00K | – | $1.41M | $1.03M | $1.27M | $1.10M | $1.58M | $1.58M | $1.15M | $2.12M | $1.20M | 12.4% | -37.7% |
| Myofunctional Therapy Services [Member] | $337.00K | $125.00K | – | $205.00K | $163.00K | $148.00K | $137.00K | $147.00K | $150.00K | $184.00K | $195.00K | $228.00K | 6.5% | +106.7% |
| Sponsorship Seminar Other [Member] | $161.00K | $205.00K | $293.00K | $236.00K | $608.00K | $328.00K | $1.29M | $294.00K | $224.00K | $122.00K | $289.00K | $101.00K | 3.1% | -73.5% |
| Billing Intelligence Services [Member] | $129.00K | $145.00K | $130.00K | $184.00K | $190.00K | $181.00K | $196.00K | $206.00K | $213.00K | $225.00K | $236.00K | $218.00K | 2.5% | -32.1% |
| VIP [Member] | $12.00K | $37.00K | $56.00K | $82.00K | $130.00K | $223.00K | – | $926.00K | $1.17M | $907.00K | $738.00K | $980.00K | 0.2% | -90.8% |
| Center Revenue [Member] | – | – | – | – | – | – | – | – | – | – | $47.00K | $43.00K | – | – |
| Appliance Sales To V I P [Member] | – | – | – | – | – | – | – | – | – | – | $1.44M | $1.42M | – | – |
| Guides [Member] | – | – | – | $790.00K | $857.00K | $540.00K | $1.16M | $375.00K | $399.00K | $529.00K | – | $271.00K | – | – |
By region
From the segment and revenue-disaggregation notes of Vivos Therapeutics's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.